Focused on Every Breath
Diagnose Asthma with Confidence
Methapharm Respiratory’s ambition is to ensure people with asthma symptoms have the right diagnosis.
Methapharm Respiratory is part of Methapharm Specialty Pharmaceuticals.
Asthma is one of the most prevalent chronic respiratory conditions globally. Ensuring that patients have the right diagnosis is the first step in improving the lives of millions of people who struggle with the disease. We provide clinicians with the diagnostic tools to accurately assess people experiencing symptoms like cough, wheeze and shortness of breath. Our globally trusted diagnostic products are recommended in the ERS/ATS guidelines as well as other international practice guidelines.
Bronchial challenge tests with Provocholine (methacholine) and Aridol (mannitol), along with measuring the level of fractional exhaled nitric oxide (FeNO) in human breath using Vivatmo pro, are objective and evidence-based measures of airway hyperresponsiveness and inflammation. Both are key features of asthma. The right diagnosis is key.
As a committed partner, we also offer training and education (CRCE) at no cost to support clinicians as they help patients along their diagnostic journey.
NOW AVAILABLE!
NOW AVAILABLE!
Consider the consequences of an incorrect diagnosis of asthma:
Ineffective treatments
Inappropriate medications
Poor quality of life
Impact on work and school performance
Consider the consequences of an incorrect diagnosis of asthma:
Ineffective treatments
Inappropriate medications
Poor quality of life
Impact on work and school performance
Blog
The Power of Self-Care in Managing Bronchiectasis
Linda Esposito, MPH I am a wellness coach and have been fortunate to live most of my life with few health issues. However, in 2016, I came back from a vacation with a cold and a lingering cough. For almost a year, my doctor and I thought my chronic cough was due to...
Technologist-Driven Protocols: Revisiting a Value-Added Service
Robert A. Brown, BS, RRT, RPFT, FAARC Technologist-Driven Protocols (also known as “Patient-Focused Pulmonary Diagnostic Assessment Plans “) may provide a roadmap for decision making, on the flow of Pulmonary Diagnostic testing, based upon the client’s Diagnosis,...
Higher Education for RTs: What’s All the Fuss?
Mike Hess, MPH, RRT, RPFT
In 2015, AARC established a goal that 80% of respiratory therapists would have at least a bachelor’s degree by 2020. It was certainly a lofty goal and based on the 2020 AARC Human Resource Survey of Respiratory Therapists, it appears we as a profession have come up a little short. Still, AARC remains committed to elevating the education level of respiratory therapists, and CoARC has established that a baccalaureate degree be the goal of any newly established RT education program.